Disease | hypoglycemia |
Phenotype | C0011849|diabetes mellitus |
Sentences | 61 |
PubMedID- 21680991 | Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus. |
PubMedID- 22291471 | For patients with type 2 diabetes mellitus, the incidence of severe hypoglycemia was 0.3 (median) episodes per 100 person-years for insulin analogs and 1.4 for human regular insulin. |
PubMedID- 26268308 | diabetes mellitus (dm) is associated with severe hypoglycemia events (shes) that vary in severity and resource consumption. |
PubMedID- 25556593 | Insulin-induced hypoglycemia in a patient with insulin-dependent diabetes mellitus resulted in chronic pontine dysfunction [10], confirming the unique vulnerability of the pons to hypoglycemia. |
PubMedID- 21339838 | Exercise-related hypoglycemia in diabetes mellitus. |
PubMedID- 23577069 | Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial. |
PubMedID- 24030920 | The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis. |
PubMedID- 24790575 | Therefore, a more cautious follow-up and education are needed to impede and treat hypoglycemia in children with diabetes mellitus. |
PubMedID- 20650471 | Conclusions: a basal insulin rate reduction was safe and effective in raising post-exercise nocturnal bg nadir and in reducing hypoglycemia in children with type 1 diabetes mellitus. |
PubMedID- 23781301 | Association of igf1 with glycemic control and occurrence of severe hypoglycemia in patients with type 1 diabetes mellitus. |
PubMedID- 23683002 | Aim: to compare the impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) treated with insulin glargine or nph insulin. |
PubMedID- 24185751 | Bariatric teams performing lsg for morbid obesity should heighten their sensitivity to postoperative hypoglycemia, even in patients with type 2 diabetes mellitus. |
PubMedID- 25779865 | Aims: accurate assessment of blood glucose fluctuation is essential for managing blood glucose control while avoiding hypoglycemia in patients with diabetes mellitus. |
PubMedID- 23916172 | Position statement: hypoglycemia management in patients with diabetes mellitus. |
PubMedID- 25937182 | Increasing trend in emergency department visits for hypoglycemia from patients with type 2 diabetes mellitus in taiwan. |
PubMedID- 25325279 | Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus. |
PubMedID- 25415670 | Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases. |
PubMedID- 23067027 | Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues bid in outpatient settings. |
PubMedID- 23926410 | Nateglinide is effective for diabetes mellitus with reactive hypoglycemia in a child with a compound heterozygous abcc8 mutation. |
PubMedID- 23434929 | Paradoxically, somatostatin concentrations are elevated at baseline and rise further during hypoglycemia in patients with type 1 diabetes mellitus who are on exogenous insulin (19). |
PubMedID- 24122616 | The performance of the proposed r-bbnn algorithm was evaluated by an application to the field of medical diagnosis using real hypoglycemia episodes in patients with type 1 diabetes mellitus. |
PubMedID- 25263824 | Quality of life and fear for hypoglycaemia in patients with type 2 diabetes mellitus. |
PubMedID- 23692715 | Neurocognitive functions were negatively affected by early onset of diagnosis, poor glycemic control and frequent hypoglycemia in children with type i diabetes mellitus. |
PubMedID- 21199269 | Aim: the objective of this systematic review and meta-analysis was to assess the effect of pramlintide on glycemic control, weight and incidence of nausea and hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) and in obese patients without diabetes (obp). |
PubMedID- 22784848 | Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. |
PubMedID- 20518101 | Diabetes: nocturnal hypoglycemia is frequent in patients with type 1 diabetes mellitus. |
PubMedID- 26417415 | Thus, further studies are required regarding fear of hypoglycemia in patients with type 2 diabetes mellitus. |
PubMedID- 23063035 | Background: self-monitoring of blood glucose (smbg) and continuous glucose monitoring (cgm) have been proven effective in improving hemoglobin a1c (hba1c) and in reducing hypoglycemia in patients with type 1 diabetes mellitus (t1dm). |
PubMedID- 24450135 | [case report; a case of type 2 diabetes mellitus with frequent hypoglycemia due to insulin antibodies after switching insulin product]. |
PubMedID- 23683963 | Hospitalizations due to severe hypoglycemia in patients with diabetes mellitus in spain. |
PubMedID- 24023652 | The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness. |
PubMedID- 26229480 | hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the french health insurance database. |
PubMedID- 22047939 | The effect of short-term use of the guardian rt continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. |
PubMedID- 20920434 | Conclusions: this article offers, for the first time, a method for smoothly reducing insulin delivery rate to prevent hypoglycemia in individuals with type 1 diabetes mellitus based on a mathematically formal assessment of hypoglycemic risk. |
PubMedID- 26289736 | diabetes mellitus (dm) is associated with severe hypoglycemia events (shes) that vary in severity and resource consumption. |
PubMedID- 25782322 | It is concluded that evaluation of quality of life and hypoglycemia-related symptoms in patients with type 2 diabetes mellitus on basal-bolus insulin therapy allows for comprehensive estimation of the effectiveness of therapy on an individual basis. |
PubMedID- 23753199 | Importance: hypoglycemia commonly occurs in patients with diabetes mellitus (dm) and may negatively influence cognitive performance. |
PubMedID- 23215826 | Is reduction in peak heart rate while exercising a sign of hypoglycaemia in athletes with diabetes mellitus. |
PubMedID- 25647516 | This study describes demographic characteristics, comorbidities, and hypoglycemia events in patients with type 2 diabetes mellitus (t2dm) identified using 2011 medicare 5% standard analytical files. |
PubMedID- 22371161 | Continuous subcutaneous insulin infusion (csii, or insulin pump therapy) reduces hba1c levels and hypoglycaemia in patients with type 1 diabetes mellitus (t1dm) compared with multiple daily insulin injections (mdi). |
PubMedID- 24548693 | Aims: the global attitude of patients and physicians 2 (gapp2) survey sought to address gaps in understanding about real-world basal insulin-taking behaviour and self-treated hypoglycaemia in patients with type 2 diabetes mellitus. |
PubMedID- 21722581 | Background: real-time continuous glucose monitoring (rt-cgm) improves hemoglobin a1c (a1c) and hypoglycemia in people with type 1 diabetes mellitus and those with type 2 diabetes mellitus (t2dm) on prandial insulin; however, it has not been tested in people with t2dm not taking prandial insulin. |
PubMedID- 24683833 | [diagnosis and assessment of hypoglycemia in patients with diabetes mellitus]. |
PubMedID- 23748506 | Background and aim: exenatide is a glucagon-like peptide-1 receptor agonist demonstrated to improve glycemic control with low hypoglycemia risk in patients with type 2 diabetes mellitus. |
PubMedID- 21231863 | The objective of this study was to compare healthcare utilization, costs, adherence, and hypoglycemia rates in patients with type 2 diabetes mellitus (t2dm) initiating rapid-acting insulin analog (raia) using prefilled pen versus vial/syringe. |
PubMedID- 25287289 | hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. |
PubMedID- 21437076 | Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus. |
PubMedID- 24895268 | hypoglycemia in people with diabetes mellitus (dm) has been potentially linked to cardiovascular morbidity and mortality. |
PubMedID- 23497433 | However this intensive diabetes treatment could be associated with an increased risk of hypoglycemia [5], particularly in patients with type 1 diabetes mellitus and patients with longstanding insulin-treated type 2 diabetes mellitus [6-9]. |
PubMedID- 21917871 | Objective: we hypothesized that opioid receptor blockade with naloxone during antecedent hypoglycemia in patients with type 1 diabetes mellitus (t1dm) would prevent the development of haaf. |
Page: 1 2